OptiLIGHT IPL is a light-based treatment that uses precise, intense broad spectrum light to address signs of dry eye disease due to meibomian gland dysfunction (MGD). MGD is the most common cause of dry eye disease, accounting for about 86% of cases.
Most existing treatments for dry eye treat the symptoms but not the underlying condition. This is where OptiLIGHT IPL is different.
The treatment addresses inflammation, which is one of the key underlying factors in MGD. OptiLIGHT was specifically developed to reach the delicate contours of the treated area safely, effectively, and gently using the OPT™ technology. It is intended for use in patients who are at least 22 years old, together with other available treatments, such as Meibomian gland expression, artificial tear lubricants, and warm compresses.
Specifically designed for the delicate area below the eye, IPL safely and effectively breaks the vicious cycle of inflammation associated with dry eye.
